| Autor: |
Bryzgunova OE; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Zaripov MM; Dispensary department 2, Novosibirsk Regional Oncology Center, Novosibirsk, Russian Federation., Skvortsova TE; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Lekchnov EA; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Grigor'eva AE; Group of microscopy, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Zaporozhchenko IA; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Morozkin ES; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation.; Centre of Oncology and Radiotherapy, Novosibirsk Research Institute of Circulation Pathology Academician E.N. Meshalkin, Novosibirsk, Russian Federation., Ryabchikova EI; Group of microscopy, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation., Yurchenko YB; Center of New Medical Technologies of ICBFM SB RAS, Novosibirsk, Russian Federation., Voitsitskiy VE; Dispensary department 2, Novosibirsk Regional Oncology Center, Novosibirsk, Russian Federation., Laktionov PP; Laboratory of molecular medicine, Institute of Chemical Biology and Fundamental Medicine CD RAS, Novosibirsk, Russian Federation.; Centre of Oncology and Radiotherapy, Novosibirsk Research Institute of Circulation Pathology Academician E.N. Meshalkin, Novosibirsk, Russian Federation. |
| Abstrakt: |
Recent studies suggest that extracellular vesicles may be the key to timely diagnosis and monitoring of genito-urological malignancies. In this study we investigated the composition and content of extracellular vesicles found in the urine of healthy donors and prostate cancer patients. Urine of 14 PCa patients and 20 healthy volunteers was clarified by low-speed centrifugation and total extracellular vesicles fraction was obtain by high-speed centrifugation. The exosome-enriched fraction was obtained by filtration of total extracellular vesicles through a 0.1 μm pore filter. Transmission electron microscopy showed that cell-free urine in both groups contained vesicles from 20 to 230 nm. Immunogold staining after ultrafiltration demonstrated that 95% and 90% of extracellular vesicles in healthy individuals and cancer patients, respectively, were exosomes. Protein, DNA and RNA concentrations as well as size distribution of extracellular vesicles in both fractions were analyzed. Only 75% of the total protein content of extracellular vesicles was associated with exosomes which amounted to 90-95% of all vesicles. Median DNA concentrations in total extracellular vesicles and exosome-enriched fractions were 18 pg/ml and 2.6 pg/ml urine, correspondingly. Urine extracellular vesicles carried a population of RNA molecules 25 nt to 200 nt in concentration of no more than 290 pg/ml of urine. Additionally, concentrations of miR-19b, miR-25, miR-125b, and miR-205 were quantified by qRT-PCR. MiRNAs were shown to be differently distributed between different fractions of extracellular vesicles. Detection of miR-19b versus miR-16 in total vesicles and exosome-enriched fractions achieved 100%/93% and 95%/79% specificity/sensitivity in distinguishing cancer patients from healthy individuals, respectively, demonstrating the diagnostic value of urine extracellular vesicles. |
